MIG is a medium-sized businesses run by experienced venture capital firms. Their experiences give rise to a competence and security, which they gladly pass on to their portfolio of businesses. Meanwhile, they have contributed to the realization of more than twenty outstanding business ideas and entrepreneurial visions of the future a bit closer to the present.
| Company | Date | Round | Size | Participants |
| SuppreMol | 5/13 | Series D | €9.5M | 4 |
| SuppreMol | 12/10 | Series C | €15.5M | 6 |
| IDENT Technology | 4/10 | Venture Round | $338k | 1 |
| Antisense Pharma | 4/10 | Series E | $17.5M | 2 |
| Biocrates Life Sciences | 3/10 | Venture Round | $1.6M | 2 |
| PDC Biotech | 2/10 | Series A | $5.5M | 2 |
| Protagen | 8/09 | Venture Round | $5.33M | 3 |
| Sovicell | 5/09 | Venture Round | 2 | |
| Protagen | 1/08 | Venture Round | €1M | 3 |
| Sovicell | 3/07 | Series D | $1.19M | 2 |
| Biocrates Life Sciences | 6/06 | Series A | $6.27M | 1 |
| Protagen | 5/06 | Series B | €3.3M | 2 |